Global Nano Bioreactor Market, By Material (Glass, Stainless Steel, Single-Use), Cell (Mammalian Cells, Bacterial Cells, Yeast Cells), Usage (Lab-Scale Production, Pilot-Scale Production, Full-Scale Production), Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy), Control Type (Manual, Automated (MFCs)), Technology (Wave-Induced Motion SUB, Stirred SUB, Single-Use Bubble Column), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.
Nano Bioreactor Market Analysis and Size
Growing demand for personalized medicines will majorly impact the bioreactors industry dynamics. The increasing incidence of chronic diseases has led to a rise in awareness initiatives associated with recent developments in personalized medicines. The growth of bioreactors in pharmaceuticals, technological advancements in bioreactors, and increasing adoption of single-use bioreactors (SUBs) and hybrid bioreactors are the major factors responsible for the growth of the bioreactor market currently.
Data Bridge Market Research analyses a growth rate in nano bioreactor market in the forecast period 2023-2030. The expected CAGR of nano bioreactor market tend to be around 8.50% in the mentioned forecast period. The market was valued at USD 3.28 billion in 2022, and it would grow upto USD 6.3 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Nano Bioreactor Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Material (Glass, Stainless Steel, Single-Use),Cell (Mammalian Cells, Bacterial Cells, Yeast Cells), Usage (Lab-Scale Production, Pilot-Scale Production, Full-Scale Production), Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy), Control Type (Manual, Automated (MFCs)), Technology (Wave-Induced Motion SUB, Stirred SUB, Single-Use Bubble Column), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Sartorius AG (Germany), Thermo Fisher Scientific (U.S.), General Electric (U.S.), Eppendorf AG (Germany), Merck KGaA (Germany), Pall Corporation (U.S.), ZETA (India), PIERRE GUERIN (France), PRaj Hipurity Systems Limited (India), Bioengineering AG (Switzerland), Infors AG (Switzerland), Solaris Biotechnology Srl. (Italy), Bbi Biotech (Germany), Bailun Biotechnology Co., Ltd. (China), PBS Biotech Inc. (U.S.), CerCell A/S (Denmark), GEA Group Aktiengesellschaft (Germany)
|
|
Market Opportunities
|
|
Market Definition
Nano bioreactors are designed to make process development and small scale production of virus for vaccines or gene therapy easy and straightforward. These are vessels that have been designed and produced to offer an effective environment for enzymes or whole cells to transform biochemicals into products. In many of the cases, the inactivation of cells or sterilization is carried out in the bioreactor such as in water treatment.
Global Nano Bioreactor Market Dynamics
Drivers
- Increasing Use of Recombinant Proteins
Recombinant proteins molecule is estimated to increase the growth of the market. Recombinant proteins have evolved as a prominent tool in medical research combined with promising effects against pathogen antigens. They are widely used as therapeutic proteins and replacement therapies, particularly in cases of hormonally active substances such as insulin and growth factor. Thus, this factor increase the market growth.
- Increasing Funding by Government Organizations
Growing investments in R&D activities leading to developing novel treatments for chronic ailments will boost the need for bioreactors at research firms. These initiatives are implemented globally to address the rising cases of diabetes, cancer, respiratory diseases, and cardiovascular disorders. Growing focus on drug development is anticipated to boost the demand for bioreactors at R&D organizations.
Opportunities
- Rising Adoption Of Single-Use Bioreactors Due To Growing Infections
Single-use bioreactors are widely used in R&D and the production of novel vaccines. With the development of new infectious diseases such as COVID-19, numerous pharma companies have increased the adoption of these technologies. Numerous end-users are converting to single-use products because of advantages such as flexible process flow, cost-effectiveness, and lower cost of the material. Numerous advancements in miniaturized single-use bioreactors are further allowing R&D organizations to assuring cost efficiency. Thus, this factor significantly increases the market growth.
- Growing Use of Hybrid Bioreactor Technology
The wide use of hybrid bioreactor technology in effective waste management has increased the expansion of the market. Several initiatives by major market players are also boosting the market growth. For instance, Beckman Coulter Life Sciences launched its next-generation Biolector XT Microbioreactor in Germany in May 2021. The BioLector XT Microbioreactor enables high-throughput strain screenings, cultivation parameter monitoring, and feeding strategy optimization. Thus, this increasing expenditure will increase the growth rate.
Restraints/Challenges
- Limited Space of Bioreactors
The biggest disadvantage of nanobioreactors lies in its scaling. Large, flat rocker bioreactors do not scale well. They usually vary from only 5 to 100 L, with their size restricted by the rate of oxygen transfer through the headspace. Thus, this restraint hinders the usage of nanobioreactors by market players and organizations.
This nano bioreactor market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the nano bioreactor market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In 2022, Getinge AB announced that their bioreactors will support the Dutch government's initiative to manufacture animal products such as meat and milk proteins directly from animal and microbial cells.
Global Nano Bioreactor Market Scope
The nano bioreactor market is segmented on the basis of material, cell, usage, molecule, control type, technology and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Material
- Glass
- Stainless Steel
- Single-Use
Cell
- Mammalian Cells
- Bacterial Cells
- Yeast Cells
Usage
- Lab-Scale Production
- Pilot-Scale Production
- Full-Scale Production
Molecule
- Monoclonal Antibodies
- Vaccines
- Recombinant Proteins
- Stem Cells
- Gene Therapy
Control Type
- Manual
- Automated (MFCs)
Technology
- Wave-Induced Motion SUB
- Stirred SUB
- Single-Use Bubble Column
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Nano Bioreactor Market Regional Analysis/Insights
The nano bioreactor market is analyzed and market size insights and trends are provided by material, cell, usage, molecule, control type, technology and end-user as referenced above.
The major countries covered in the nano bioreactor market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific has been witnessing a positive growth for nano bioreactor market throughout the forecast period because of the numerous strategies, such as mergers and acquisitions research and development and product launches. Furthermore, the increasing demand for biopharmaceutical products in the region and the focus on increasing localized production are anticipated to have a major impact on the market during the forecast period.
North America dominates the market due to the increase in collaboration among the industry and academic institutions. The U.S. holds the majority of the market in the North American region as pharmaceuticals and other hi-tech product makers have announced multimillion-dollar investments to expand manufacturing capabilities.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Nano Bioreactor Market Share Analysis
The nano bioreactor market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related nano bioreactor market.
Key players operating in the nano bioreactor market include:
- Sartorius AG (Germany)
- Thermo Fisher Scientific (U.S.)
- General Electric (U.S.)
- Eppendorf AG (Germany)
- Merck KGaA (Germany)
- Pall Corporation (U.S.)
- ZETA (India)
- PIERRE GUERIN (France)
- PRaj Hipurity Systems Limited (India)
- Bioengineering AG (Switzerland)
- Infors AG (Switzerland)
- Solaris Biotechnology Srl. (Italy)
- Bbi Biotech (Germany)
- Bailun Biotechnology Co., Ltd. (China)
- PBS Biotech Inc. (U.S.)
- CerCell A/S (Denmark)
- GEA Group Aktiengesellschaft (Germany)
SKU-